OncologyTube Professional - Patients Click Here
23,678 video views
Loading........
Description: SAN FRANCISCO—The ability of cancer cells to evolve clonally into molecularly distinct strands needs to be considered when selecting targeted therapies to treat renal cancer, according to Dr Tom Powle...
02:37
SAN FRANCISCO—The ability of cancer cells to evolve clonally into molecularly distinct strands needs to be considered when selecting targeted therapies to treat renal cancer, according to Dr Tom Powles MBBS, MRCP, MD speaking at the ASCO GU Cancers Symposium here. Dr Tomasz Beer, MD FACP from Orego...
by:AudioMedica | 2822 views
06:37
NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblastic leukemia and otherwise had very short life expectancies. Stephan A Grupp, MD, PhD from the Unive...
by:AudioMedica | 3373 views
02:33
LONDON— Researchers have shown that endometrial cancer — and hopefully ovarian cancer too — could potentially be detected much earlier than at present — or even prevented altogether — by looking for ‘silencing’ by DNA methylation of the HAND2 gene: an ‘epigenetic’ process which is not inherited but ...
by:AudioMedica | 2739 views
01:31
ORLANDO, FLORIDA—Patient​s receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months but have fewer side effects — according to study findings announced at the 2013 ASCO Genitourinary Cancers Symposium in Orlando...
by:AudioMedica | 2176 views
01:55
SAN FRANCISCO—New research has shown the alpha-emitting drug radium 233 to be a “benign” therapy with no major toxicities — while effectively targeting bone metastatic disease and increasing overall survival in patients with castration-resi​stant prostate cancer whether or not they had received docet...
by:AudioMedica | 2879 views
01:24
SAN FRANCISCO— The orally administered androgen receptor blocker enzalutamide significantly extended both overall survival and radiographicall​y determined progression-fre​e survival in men whose metastatic castration-resi​stant prostate cancer was asymptomatic or mildly symptomatic and had not been tr...
by:AudioMedica | 2322 views
02:30
NEW ORLEANS—A new oral tyrosine kinase inhibitor drug — idelalisib — has proved effective — and to have low toxicity — in patients with chronic lymphocytic leukaemia (CLL). Richard Furman MD from Weill Cornell Medical College in New York announced findings at the American Society of Hematology Ann...
by:AudioMedica | 1612 views
01:42
The rare, fatal lympho-prolifer​ative condition: Multicentric Castleman's Disease — MCD — could soon be treatable following findings announced at the American Society of Hematology annual meeting in New Orleans. Dr. Raymond S Wong MD, PhD — who is a hematology consultant at the Prince of Wales Hospi...
by:AudioMedica | 1573 views
01:28
WASHINGTON DC—A new type of immunotherapy has brought responses in children with acute lymphoblastic leukaemia in relapse who had no other options to prevent the progress of this fatal phase of the disease. At the American Association for Cancer Research annual meeting Dr Daniel W. Lee from the Pedi...
by:AudioMedica | 1091 views
02:06
CAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Cambridge Institute, University of Cambridge, report in the New England Journal of Medicine that circulating tumour DNA ...
by:AudioMedica | 1225 views

About AudioMedica


Links
Channel Url: